TABLE 3.

Summary of the quantification of the full capsids for AAV6, AAV8, AAV9, and AAVrh.10

AAV serotype (capsid)	Utilized rep variant	Biological replicate	Percentage of “full” capsids	Mean (%)
AAV6	R2	I	12	17
		II	18
		III	20
	R1hc2	I	37	43
		II	45
		III	46
	R2d1	I	20	28
		II	25
		III	39
	R8d1c2	I	37	36
		II	38
		III	32
AAV8	R2	I	18	20
		II	23
		III	19
	R8d1c2	I	28	36
		II	47
		III	34
	R1c2	I	41	33
		II	32
		III	27
	R8*c2	I	62	43
		II	30
		III	36
AAV9	R2	I	18	18
		II	14
		III	22
	R8d1c2	I	36	32
		II	29
		III	31
AAVrh.10	R2	I	12	17
		II	28
		III	11
	R8d1c2	I	27	31
		II	34
		III	31